Jeena Sikho Lifecare Limited has informed the Exchange about Board Approval of ESOP Scheme 2025 subject to approval of the Shareholders.
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Jeena Sikho Lifecare approved several items at its August 27, 2025 meeting. A new Employee Stock Option Scheme (ESOP 2025) was cleared, offering up to 2,50,000 stock options to eligible employees and directors at an exercise price of just Rs. 2 per share (equal to face value), subject to shareholder approval. A final dividend of Rs. 1.10 per equity share (on Rs. 2 face value) for FY25 was announced, with the record date fixed as September 22, 2025. The company appointed Mr. Sahil Jain as Chief Operating Officer and re-designated Ms. Shreya Grover (daughter of MD Manish Grover) from Non-Executive Director to Whole-Time Director for a five-year term. M/s Ankur Singh & Associates was appointed as Secretarial Auditor for five years. The 8th Annual General Meeting is scheduled for September 29, 2025, in Zirakpur, Punjab.
Shareholders will receive a Rs. 1.10 per share dividend if approved at the AGM, providing some near-term cash return. The ESOP at face value pricing, while small at 2.5 lakh shares, signals a diluted benefit for staff rather than significant dilution risk. Key leadership transitions including a new COO and a young Whole-Time Director from the promoter family point to an evolving management team focused on expansion of Ayurveda hospitals and OTC products.